Status:
RECRUITING
MISP 60528 Pneumococcal Vaccination
Lead Sponsor:
Montefiore Medical Center
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Heart Transplant Infection Prevention
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to use two different blood tests (ELISA and OPA) to study response to pneumococcal vaccination administered as per standard guidelines in patients who are undergoing workup for heart t...
Detailed Description
The patients will be receiving vaccination consistent with standard of care guidelines, regardless of study participation. The additional risk of study participation would be the risks associated with...
Eligibility Criteria
Inclusion
- Age 18 or over
- Either undergoing evaluation for heart transplant (with or without LVAD receipt), or having received a heart transplant
- Receiving a dose of PCV15 or PPSV23 (or both sequentially) concordant with AST guidelines
Exclusion
- Infants and children under age 18
- Subjects without the capacity to consent
- Pregnancy
- Already up to date on pneumococcal vaccination or declining vaccination
Key Trial Info
Start Date :
June 10 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT04845945
Start Date
June 10 2021
End Date
July 1 2026
Last Update
January 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Montefiore Medical Center, Infectious Diseases
The Bronx, New York, United States, 10467